Search results - Portal of Medical Data Models (MDM-Portal)

Filter search results
Select data models

Selected data models

You must log in to select data models for download or further analysis.

2 Search results.

GSK AVA100193 Rosiglitazone in Alzheimer´s Disease - Visit 2-5 - Visit 2-5

- 9/20/17 - 1 form, 4 itemgroups, 112 items, 1 language

Itemgroups: Visit 2, Visit 3, Visit 4, Visit 5

A 24 week double-blind, randomised, placebo-controlled, parallel-group dose-ranging study to investigate the effects of rosiglitazone (extended release tablets) on cognition in subjects with mild to moderate Alzheimer's disease.

visit 2 randomization starting dose of ropinirole Parkinson's Disease 101468/166

- 9/4/17 - 1 form, 2 itemgroups, 5 items, 1 language

Itemgroups: administrative data, randomization

Study ID: 101468/166 Clinical Study ID: SKF-101468/166 Study Title: A Phase II, randomised, double-blind, active-controlled, dose-escalation study to determine the maximum well-tolerated starting dose of a new formulation of ropinirole in Parkinson's Disease patients not receiving other dopaminergic therapies Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 2 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: requip Study Indication: Parkinson Disease

Please use this form for feedback, questions and suggestions for improvements.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.